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Objective: To assess temporal trends in 1-year healthcare costs 
and outcome of intensive care for traumatic brain injury in Finland.
Design: Retrospective observational cohort study.
Setting: Multicenter study including four tertiary ICUs.
Patients: Three thousand fifty-one adult patients (≥ 18 yr) with 
significant traumatic brain injury treated in a tertiary ICU during 
2003–2013.
Intervention: None.
Measurements and Main Results: Total 1-year healthcare costs 
included the index hospitalization costs, rehabilitation unit costs, 
and social security reimbursements. All costs are reported as 
2013 U.S. dollars ($). Outcomes were 1-year mortality and perma-
nent disability. Multivariate regression models, adjusting for case-
mix, were used to assess temporal trends in costs and outcome 
in predefined Glasgow Coma Scale (3–8, 9–12, and 13–15) and 
age (18–40, 41–64, and ≥ 65 yr) subgroups. Overall 1-year sur-
vival was 76% (n = 2,304), and of 1-year survivors, 37% (n = 
850) were permanently disabled. Mean unadjusted 1-year health-
care cost was $39,809 (95% CI, $38,144–$41,473) per patient. 
Adjusted healthcare costs decreased only in the Glasgow Coma 
Scale 13–15 and 65 years and older subgroups, due to lower 
rehabilitation costs. Adjusted 1-year mortality did not change in 
any subgroup (p < 0.05 for all subgroups). Adjusted risk of perma-
nent disability decreased significantly in all subgroups (p < 0.05).
Conclusion: During the last decade, healthcare costs of ICU-
admitted traumatic brain injury patients have remained largely the DOI: 10.1097/CCM.0000000000002959
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same in Finland. No change in mortality was noted, but the risk 
for permanent disability decreased significantly. Thus, our results 
suggest that cost-effectiveness of traumatic brain injury care 
has improved during the past decade in Finland. (Crit Care Med 
2018; 46:e302–e309)
Key Words: cost-effectiveness; intensive care unit; outcome; 
traumatic brain injury; treatment cost; treatment intensity
Traumatic brain injury (TBI) is a globally growing prob-lem (1, 2). In Europe and the United States, the increas-ing occurence of elderly people falling is changing the 
epidemiology of TBI, and the rising age of patients treated in 
ICUs has drastically increased the demand for ICU beds (3–6).
Intensive care treatment is expensive, comprising 4% of 
the national healthcare expenditures and 0.5% of the national 
gross domestic product in the United States alone (5). Yet, 
extensive cost-analysis data for ICU-treated TBI patients is 
virtually nonexistent. In Finland, all specialized tertiary care 
of TBI patients (including neurosurgical and neurointensive 
care) has for several decades been centralized to five publi-
cally funded university hospitals (7). Further, the same Social 
Insurance Institute (SII) covers all Finnish citizens, allowing 
for a unique opportunity to comprehensively assess the eco-
nomic burden of TBI.
Our primary aim was to evaluate temporal trends in 1-year 
healthcare costs and outcome of intensive care for patients 
with TBI from 2003 to 2013 treated in tertiary Finnish ICUs. 
As secondary aims, we aimed to assess temporal changes in 
treatment intensity and to assess cost-effectiveness in some 
clinically relevant predefined subgroups. We hypothesized that 
healthcare costs and treatment intensity have increased with-
out any change in patient outcome.
METHODS
The ethics committee of the Operative Division of Helsinki 
University Hospital, the Finnish National Institute for Health 
and Welfare, Statistics Finland, the Social Insurance Institu-
tion, the Office of the Data Protection Ombudsman, and all the 
participating university hospitals’ ethics committees approved 
this study.
Study Design and Population
We performed a multicenter retrospective observational study 
using data that were prospectively collected from the Finn-
ish Intensive Care Consortium (FICC) database. The FICC 
database is a nationwide prospectively data collecting data-
base including all ICU-treated patients from the majority of 
all ICUs in Finland (7–9). In Finland, all specialized tertiary 
intensive care of TBI patients is centralized to five tertiary 
ICUs. Four of these ICUs participate in the FICC. From these 
four tertiary ICUs, we included all adult TBI patients (age ≥ 18 
yr) admitted from January 1, 2003 to December 31, 2013 (read-
missions excluded). Figure 1 shows a flow chart of included 
and excluded patients.
Outcome Variables
We used 1-year mortality as the primary outcome of interest. Data 
on the date of death were obtained through the Finnish popula-
tion register (available for all patients) and the archive of death 
certificates. As a secondary outcome of interest, we used a sur-
rogate variable of permanent disability, defined as if the patient 
was granted a permanent disability allowance or disability pen-
sion by the SII. The SII is a Finnish government agency funded by 
tax money, insurance payments, and municipalities that provide 
all social security payments in Finland. The SII mandates one to 
be unable to independently carry out daily activities (e.g., self-
hygiene, basic housekeeping, take care of things outside the home) 
or to be unable to return to work, for a minimum of 1 consecutive 
year (following the injury), in order to grant a permanent disabil-
ity allowance or disability pension. Thus, we defined all patients 
who were granted permanent disability allowance or permanent 
disability pension from the SII (by September 30, 2016) as being 
permanently disabled. The SII’s criteria for granting permanent 
disability allowances did not change during the study period. We 
also investigated hospital mortality, which we retrieved directly 
from the FICC database. The Therapeutic Intervention Scoring 
System (TISS) 76 was used as a marker of ICU treatment inten-
sity. The TISS-76 includes a set of 76 selected therapies used in 
intensive care and was developed to quantify the intensity of care 
required by critically ill patients (10, 11). The TISS-76 variables are 
entered to the FICC database, as part of standard clinical practice.
Cost Data
We obtained all direct costs for the first year following TBI, 
including index hospitalization costs, rehabilitation hospital 
costs, and social security costs. We obtained direct cost data 
regarding the patients’ index hospitalization directly from 
the university hospitals’ invoicing departments (referred to as 
“university hospital costs”). These include costs for the whole 
treatment period, including all the incurred expenses (e.g., 
personnel costs, surgery, ICU stay, laboratory costs, radio-
logic costs, and ward stay). We found the rehabilitation unit 
costs (referred to as “rehabilitation unit costs”) by calculat-
ing the length of stay in the rehabilitation unit multiplied by 
the average price of 1 ward day in the designated level of care 
Figure 1. Flow chart showing the inclusion and exclusion process.  
FICC = Finnish Intensive Care Consortium, GCS = Glasgow Coma Scale,  
TBI = traumatic brain injury, TISS-76 = Therapeutic Intervention Scoring 
System 76.
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unit according to the report from the Finnish National Insti-
tute for Health and Welfare (12). We obtained social security 
costs, including disability allowances, sickness allowances, 
private physician and physiotherapist expenses, prescription 
drug expenses, and medical travel costs directly from the SII 
(referred to as “social security costs”). We included all reim-
bursements granted for a period of up to 1 year after the TBI. 
The total 1-year healthcare cost was calculated as the sum of 
the university hospital costs, rehabilitation unit costs, and 
social security costs.
To evaluate cost-effectiveness, we calculated the effective 
cost per survivor (ECPS) and effective cost per independent 
survivor (ECPIS), which is defined as the cost for all patients 
divided by the number of (independent) survivors (13). The 
ECPS and ECPIS were calculated for all patients and for the 
predefined subgroups (see “subgroup analyses”).
We adjusted all costs according to the consumer price index 
(CPI) in Finland to 2013 Euros (14). The CPI-adjusted costs 
were calculated as follows:





All CPI-adjusted costs were then converted to 2013 U.S. 
dollars (USD) using the Purchasing Power Parities (PPP) 
(2013 PPP [Finnish national currency unit in 2013/USD in 
2013] = 0.905) (15).
Statistical Methods
We used SPSS Statistics 24.0 for mac OS (IBM Corp, Armonk, 
NY) and Stata Statistical Software for mac OS (StataCorp LP, 
College Station, TX) for the statistical analyses.
To adjust for case-mix over the years, we created a severity 
of illness model that included age, gender, Glasgow Coma Scale 
(GCS) score, chronic comorbidity, World Health Organization/
Eastern Cooperative Oncology Group classification, Marshall 
CT classification, and Simplified Acute Physiology Score 
(SAPS) II total score (excluding age, GCS score, and chronic 
comorbidity). The GCS score is defined as the worst measured 
GCS score during the first ICU day in accordance to the Acute 
Physiology and Chronic Health Evaluation II definition (16). 
The last reliable GCS was used for intubated and/or sedated 
patients (7). The area under receiver operator curve (AUC) 
was 0.86 (95% CI, 0.85–0.87) for 1-year mortality prediction, 
indicating excellent discriminative power, and 0.67 (95% CI, 
0.66–0.69) for permanent disability prediction, indicating sat-
isfactory discriminative power. Temporal trends in costs and 
treatment intensity were evaluated using linear regression and 
temporal trends in 1-year mortality and permanent disability 
were evaluated using logistic regression, all models adjusting 
for the severity of illness model and using year of admission as 
a continuous variable (8).
Adjusted rates of 1-year mortality and permanent disability 
were reported as odds ratios, risk-adjusted mortality (RAMR), 
and risk-adjusted disability (RADR) rates. The RAMR and 
RADR were calculated as the ratio between the observed and 
predicted outcome multiplied by the overall outcome rate in 
the specific patient group. The RAMR and RADR represented 
the estimated outcome rate if the patient case-mix was con-
stant for each year (8).
The study was done in accordance with the Strengthening 
the Reporting of Observational studies in Epidemiology 
guidelines (Supplemental Methods 1, Supplemental Digital 
Content 1, http://links.lww.com/CCM/D196).
Subgroup Analyses
We divided the patients into predefined clinically relevant sub-
groups according to GCS score and age. The GCS subgroups 
were 3–8 (severe TBI), 9–12 (moderate TBI), and 13–15 (mild 
TBI). The age subgroups were 18–40 years (young), 41–64 
years (middle-aged), and 65 years and older (old). The ECPS 
and ECPIS were calculated separately in all six subgroups.
RESULTS
The study population consisted of 3,051 patients (Fig. 1). The 
baseline characteristics are presented in Table 1. Forty-seven 
percentage were classified as severe TBI (GCS, 3–8), 20% as 
moderate TBI (GCS, 9–12), and 33% as mild TBI (GCS, 13–15). 
Twenty-four percentage were classified as young, 47% as mid-
dle-aged, and 29% as old. Patients with mild TBI were somewhat 
younger than patients with moderate or severe TBI (Supple-
mental Table 1, Supplemental Digital Content 2, http://links.
lww.com/CCM/D197).
The number of ICU-admitted TBI patients increased 
from 151 in 2003 to 326 in 2013. In comparison to all ICU 
admissions during 2003–2013, the relative proportion 
of TBI admissions increased from approximately 1% per 
year to approximately 2% per year (Supplemental Table 2, 
Supplemental Digital Content 3, http://links.lww.com/CCM/
D198). The major change was a higher proportion of less 
severely injured TBIs (higher GCS, lower SAPS II). There were 
no changes in restriction of withdrawal of intensive care dur-
ing the study period (range, 6–11%; p = 461).
Unadjusted hospital mortality was 12% and unadjusted 
1-year mortality was 24% (for outcomes in the subgroups, see 
Supplemental Table 3, Supplemental Digital Content 4, http://
links.lww.com/CCM/D199). Permanent disability in 1-year 
survivors was 37%.
Temporal Trends in Healthcare Costs
Mean 1-year healthcare cost per patient was $39,809 (95% CI, 
$38,144–$41,473). University hospital costs constituted 44%, 
rehabilitation unit costs were 42%, and social security costs 
represented 14% of the 1-year healthcare costs (Supplemental 
Fig. 1, Supplemental Digital Content 5, http://links.lww.com/
CCM/D200; legend, Supplemental Digital Content 8, http://
links.lww.com/CCM/D203).
Including all patients, case-mix adjusted 1-year healthcare 
costs decreased by a mean of $740 (95% CI, $1,294–$187) per 
year; university hospital costs increased by a mean of $290 (95% 
CI, $28–$550) per year; rehabilitation unit costs decreased by a 
mean of $1,107 (95% CI, $1,492–$723) per year; social security 
costs did not significantly change during the study period.
Online Clinical Investigations
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In subgroup analysis, healthcare costs decreased only in 
patients with mild TBI and in old TBI patients (Table 2). 
In the mild TBI group, the cost reduction was due to lower 
rehabilitation costs (mean annual reduction, $890). In the old 
age group, the cost reduction was due to lower rehabilitation 
costs (mean annual reduction, $2,154), although university 
hospital costs increased slightly (mean annual increase, $658). 
In patients with severe and moderate TBI, university hospi-
tal costs increased (mean annual increase, $1,056 and $576, 
respectively), rehabilitation costs decreased (mean annual 
decrease, $1,046 and $400, respectively), and social security 
costs increased (mean annual increase, $210 and $316, respec-
tively). University hospital costs did not significantly change in 
the young- and middle-aged subgroups.
The sum of total healthcare costs for all 3,051 patients was 
$121.5 million (mean, $11.0 million/yr) (Supplemental Fig. 2, 
Supplemental Digital Content 6, http://links.lww.com/CCM/
D201; legend, Supplemental Digital Content 8, http://links.
lww.com/CCM/D203). In 2003, the sum of all costs was $7.1 
million, and in 2013, the sum increased to $10.8 million.
Temporal Trends in Outcome
Overall, 1-year RAMR was 25% (95% CI, 18–28%) and did not 
significantly change during the study period (p = 0.14) (Fig. 2). 
Nor did the 1-year RAMR change in any of the predefined study 
groups (Table 3).
RADR decreased significantly during the study period from 
37% (95% CI, 29–45%) in 2003 to 19% (95% CI, 16–25%) in 
2013 (Fig. 2). Case-mix adjusted risk for permanent disability 
decreased in all subgroups (Table 3).
Temporal Trends in Treatment Intensity
Case-mix adjusted treatment intensity decreased significantly 
during the study period by a mean of 0.21 of the mean daily 
TISS-76 (p < 0.001). Treatment intensity decreased signifi-
cantly only in the young, middle-aged, and mild TBI subgroups 
(Table 2). Treatment intensity did not significantly increase in 
any subgroup.
Cost-Effectiveness
The overall ECPS was $52,716, and the overall ECPIS was 
$83,533. The ECPS and ECPIS were systematically higher in 
older patients and in patients with lower GCS scores (Supple-
mental Fig. 3, Supplemental Digital Content 7, http://links.
lww.com/CCM/D202; legend, Supplemental Digital Content 8, 
http://links.lww.com/CCM/D203). The ECPIS was approxi-
mately two times lower among young patients compared with 
old patients irrespective of GCS. The difference in ECPIS was 
almost as pronounced between young and old-aged patients 
as it was between young and middle-aged patients, except for 
in mild TBIs, where middle-aged patients had a notably better 
ECPS and ECPIS than old patients.
DISCUSSION
Key Findings
In this comprehensive cost-effectiveness study, 1-year health-
care costs following ICU admission after significant TBI has 
remained largely the same in Finland from 2003 to 2013. A 
TABLE 1. Patient Baseline Characteristics
Variables
All Patients  
(n = 3,051)
Age (yr), median (IQR) 56 (41–67)
 18–40, n (%) 741 (24)
 41–64, n (%) 1,429 (47)
 ≥ 65, n (%) 881 (29)
Glasgow Coma Scale score, median (IQR) 9 (5–14)
 3–8, n (%) 1,441 (47)
 9–12, n (%) 594 (20)
 13–15, n (%) 1,016 (33)
Females, n (%) 698 (23)
Preadmission performance statusa, n (%)  
 Fit for work or equal 1,865 (61)
 Unfit for work, but independent in  
self-care
954 (31)
 Partially dependent in self-care 178 (6)
 Totally dependent in self-care 54 (2)
Significant chronic comorbidityb, n (%) 261 (9)
Operative admission, n (%) 1,108 (36)
Mechanical ventilation, n (%) 2,039 (67)
Intracranial pressure monitoring, n (%) 722 (24)
LOS university neurosurgical ICU (d), 
median (IQR)
2 (1–4)
LOS university hospital (d), median (IQR) 6 (3–11)
Acute Physiology and Chronic Health 
Evaluation II score, median (IQR)
19 (13–24)
Simplified Acute Physiology Score II, 
median (IQR)
35 (24–50)
Sequential Organ Failure Assessment 
scorec, median (IQR)
6 (3–8)
Marshall CT classification, n (%)  
 I 316 (10)
 II 982 (32)
 III 287 (9)
 IV 45 (2)
 Evacuated mass lesion/nonevacuated 
mass lesion
1,421 (47)
IQR = interquartile range, LOS = length of stay.
a A modified World Health Organization/Eastern Cooperative Oncology Group 
classification system implemented by the Finnish Intensive Care Consortium.
b Any chronic comorbidity according to Acute Physiology and Chronic Health 
Evaluation II or Simplified Acute Physiology Score II.
c Missing for seven patients.
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reduction in healthcare costs was noted in mild and in older 
TBI patients, due to lower rehabilitation costs. No reduc-
tion in healthcare costs was noted in patients with moderate 
and severe TBI, although university hospital costs increased 
in these groups. There was no significant change in adjusted 
1-year mortality in any of the subgroups. Yet, adjusted risk for 
permanent disability decreased in all subgroups, suggesting 
improved cost-effectiveness of TBI care.
Although university hospital costs increased in some sub-
groups, it did not affect total healthcare costs, as rehabilitation 
TABLE 2. Temporal Change in Case-Mix Adjusted Costs
Mean Annual Change in Total 1-yr Cost
p Mean Annual Change 95% CI
Total healthcare costs –740 –1,294 to –187 0.009
GCS 3–8    
 Total healthcare costs 220 –690 to 1,129 0.67
 University hospital costs 1,056 619–1,492 < 0.001
 Rehabilitation costs –1,046 –1,681 to –411 0.001
 Social security costs 210 74–346 0.002
GCS 9–12    
 Total healthcare costs 491 –502 to 1,485 0.33
 University hospital costs 576 60–1,091 0.029
 Rehabilitation costs –400 –1,069 to 268 0.24
 Social security costs 316 110–522 0.003
GCS 13–15    
 Total healthcare costs –1,119 –1,901 to –336 0.005
 University hospital costs –137 –455 to 182 0.40
 Rehabilitation costs –890 –1,484 to –295 0.003
 Social security costs –92 –245 to 62 0.24
Age 18–40 yr    
 Total healthcare costs –43 –1,310 to 1,224 0.95
 University hospital costs 453 –233 to 1,138 0.20
 Rehabilitation costs –526 –1,212 to 159 0.13
 Social security costs 30 –158 to 219 0.75
Age 41–64 yr    
 Total healthcare costs –471 –1,238 to 297 0.23
 University hospital costs 205 –154 to 565 0.26
 Rehabilitation costs –873 –1,392 to –355 0.001
 Social security costs 197 43–351 0.012
Age ≥ 65 yr    
 Total healthcare costs –1,401 –2,405 to –414 0.006
 University hospital costs 658 308–1,008 < 0.001
 Rehabilitation costs –2,154 –3,028 to –1,281 < 0.001
 Social security costs 86 2–171 0.045
GCS = Glasgow Coma Scale.
Annual changes in costs and treatment intensity were assessed using linear regression adjusting for a severity of illness model including age, gender, GCS 
score, significant chronic comorbidity, World Health Organization/Eastern Cooperative Oncology Group classification, Marshall CT classification, Simplified 
Acute Physiology Score II total score without the age, GCS score, and chronic comorbidity components. Total healthcare costs include university hospital costs, 
rehabilitation unit costs, and social security costs. Costs are expressed as 2013 U.S. dollars ($).
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costs decreased accordingly. Rehabilitation costs was calculated 
as length of stay in the rehabilitation unit times a constant 
price given by the Finnish National Institute for Health and 
Welfare (12). Thus, the only possibility of lower rehabilitation 
costs is shorter rehabilitation times or a transition to lower 
level of care rehabilitation units, that are associated with lower 
costs. The reduction in rehabilitation costs did, however, not 
reflect in worse outcomes as risk of mortality and permanent 
disability did not increase.
Interestingly, changes in treatment intensity did not cor-
relate with university hospital costs. University hospital costs 
remained the same in the mild TBI-, young-, and old-subgroups, 
despite decreased treatment intensity. Conversely, treatment 
intensity did not change in the severe TBI-, moderate TBI-, and 
old-subgroups, although these 
subgroups’ university hospi-
tal costs increased. Treatment 
intensity was measured using 
the TISS-76 (11). The TISS-76 
might, however, be considered 
a suboptimal instrument to 
evaluate treatment intensity 
in TBI patients, as it does not 
include neurointensive-specific 
treatment interventions. Using, 
for example, the therapy inten-
sity level that was specifically 
designed to measure treat-
ment intensity in TBI patients 
might have revealed differ-
ent results (17). Although we 
cannot verify this, modern 
monitoring (e.g., brain tissue 
oxygen, brain tissue lactate and 
pyruvate, temperature, and 
electroencephalography) and 
imaging (e.g., MRI and CT per-
fusion imaging) have probably 
increased, leading to increased 
costs. The benefits on patient 
outcome and treatment cost-
effectiveness of implementing 
such novel modalities should 
be addressed in future studies.
In Finland, the propor-
tion of patients admitted 
to tertiary ICUs due to TBI, 
in comparison with other 
admission causes, have dou-
bled during the last decade. 
This appears largely caused 
by an increasing number 
of mild TBIs being admit-
ted to ICUs, leading to a less 
severely injured TBI popu-
lation in the later years. In 
addition, more elderly patients are treated in tertiary 
ICUs. As a result, the total sum of healthcare costs result-
ing from tertiary ICU care of TBI have increased signifi-
cantly. The sum of 1-year healthcare cost for all patients 
was approximately $122 millions. Of this, $54 millions, or 
45% of the overall sum, went to independent survivors. 
Cost-effectiveness was notably better among young TBI 
patients irrespective of TBI severity. For example, in young 
patients with severe TBI, this ratio was 53%, but it was only 
31% in old severe TBI patients. Thus, most of the resources 
used do not result in a favorable patient outcome. Given 
an aging population, this will pose great challenges to the 
neurosurgical and neurocritical care communities in the 
future.
Figure 2. Temporal trend in 1-year risk-adjusted mortality rate (RAMR) and risk-adjusted permanent disability 
rate (RADR). The RAMR represents the estimated 1-year mortality rate if the patient case-mix was identical 
for each year. RADR represents the estimated disability rate if the patient case-mix was identical for each year. 
Overall, the 1-year RAMR was 25% (95% CI, 18–28%) and did not significantly change during the study period 
(p = 0.14). Overall, RADR decreased from 37% in 2003 to 19% in 2013. An increasing admission year was 
significantly associated with a decreased risk for permanent disability (odds ratio, 0.92; 95% CI, 0.90–0.95).
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Cost Comparison With Previous TBI Studies
Studies looking at overall healthcare costs following ICU 
admission after TBI are scarce. A study from Canada estimated 
that the mean overall 1-year postadmission cost after TBI 
was $32,132 (expressed in 2007 Canadian dollars, converts to 
$43,791 in 2013 USD) (18). A study from New Zealand esti-
mated that the overall first-year cost per moderate-to-severe 
TBI was $21,379 (expressed in 2010 USD, converts to $22,840 
in 2013 USD), including both direct and indirect costs (19). 
A study from the United States reported total costs up to 6 
months after admission to be $48,988 (expressed in USD, not 
specified for which year, study was conducted from 2003 to 
2005, converts to $58,434 in 2013 USD) (20). Another study 
from the United States investigating direct hospital costs asso-
ciated with TBI found an average price to be $8,189 for moder-
ate TBI, $14,603 for serious TBI, and $33,537 for critical TBI 
(expressed in 1999 USD, converts to $11,451, $20,419, and 
$46,895 in 2013 USD, respectively) (21). A study from England 
and Wales found that the mean direct hospitalization costs was 
£15,462 (expressed in 2004 pound sterling, converts to $13,119 
in 2013 USD) (22). In comparison with the previous studies, 
the mean total healthcare cost in the present study was $39,809 
(expressed in 2013 USD), which is in line with or somewhat 
higher than the figures reported in previous studies.
Cost Comparison With Other Critical Care Illnesses
Like in TBI, recent studies reporting overall healthcare costs 
in ICU-treated patients are scarce. In patients treated for 
acute renal failure, the mean cost for one 6-month survivor 
was approximately $80,026 (expressed in 1993 USD, converts 
to $129,015 in 2013 USD) (23). Another study showed that 
the median overall 5-year cost per acute renal failure hospi-
tal survivor was €64,285 (expressed in Euros, not specified for 
which year, study was conducted from 2000 to 2002, converts 
to $71,507 in 2013 USD) (24). In critically ill cancer patients, 
the cost per gained life ranged from $82,845 to $189,339 
(expressed in USD, not specified for which year, study was 
conducted from 1988 to 1990, converts to $147,661$–$337,474 
in 2013 USD) (25). In patients admitted to the ICU after sud-
den cardiac arrest with in-hospital or out-of-hospital cardio-
pulmonary resuscitation, the mean cost per hospital survivor 
was nearly €49,952 (expressed in Euros, not specified for 
which year, study was conducted from 1999 to 2001, converts 
to $55,681 in 2013 USD) (26). In comparison with these ICU-
treated illnesses, TBI treatment seems cost-effective, especially 
in younger patients, where the mean ECPIS for severe TBI was 
$104,741 (expressed in 2013 USD), which is low, considering 
that these patients may return to full-time employment.
Strengths and Limitations
A strength of the current study is that it was conducted in a pub-
lic tax-funded healthcare and system (independent of personal 
insurances), which allowed accurate assessment of healthcare 
costs. In addition, by using the high-quality ICU database, we 
were able to include four of five units providing specialized 
intensive care for TBI patients, making our study population 
TABLE 3. Temporal Change in Case-Mix 
Adjusted 1-Year Mortality, Permanent 
Disability, and Treatment Intensity
Patient Groups OR 95% CI p
Mean Annual Change in Risk of 1-Yr Mortality 
Overall 0.98 0.94–1.01 0.14
GCS subgroups    
 3–8 0.98 0.94–1.03 0.42
 9–12 0.95 0.87–1.04 0.27
 13–15 0.94 0.85–1.03 0.15
Age subgroups (yr)    
 18–40 0.91 0.82–1.00 0.06
 41–64 0.95 0.90–1.00 0.06
 ≥ 65 1.00 0.95–1.06 0.88
Mean Annual Change in Risk of Permanent Disability
Overall 0.92 0.90–0.95 < 0.001
GCS subgroups    
 3–8 0.96 0.92–0.99 0.026
 9–12 0.92 0.87–0.98 0.010
 13–15 0.86 0.82–0.91 < 0.001
Age subgroups (yr)    
 18–40 0.85 0.79–0.92 < 0.001
 41–64 0.93 0.89–0.96 < 0.001




Change 95% CI  p
Mean Annual Change in Treatment Intensity  
(Therapeutic Intervention Scoring System 76) Per Patient
Overall –0.21 –0.30 to –0.12 < 0.001
GCS subgroups    
 3–8 0.12 –0.01 to 0.24 0.07
 9–12 0.05 –0.15 to 0.24 0.63
 13–15 –0.38 –0.52 to –0.25 < 0.001
Age subgroups (yr)    
 18–40 –0.20 –0.39 to 0.00 0.045
 41–64 –0.21 –0.33 to –0.09 0.001
 ≥ 65 0.00 –0.15 to 0.15 0.96
GCS = Glasgow Coma Scale, OR = odds ratio.
Independent effect of admission year on 1-year mortality and permanent 
disability rates using logistic regression adjusting for a severity of illness model 
including age, gender, GCS score, significant chronic comorbidity, World Health 
Organization/Eastern Cooperative Oncology Group classification, Marshall CT 
classification, Simplified Acute Physiology Score II total score without the age, 
GCS score, and chronic comorbidity components. Annual changes in treatment 
intensity (Therapeutic Intervention Scoring System 76) was assessed using 
linear regression adjusting for the same severity of illness model.
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largely representative of the whole Finnish population. Still, 
there are some limitations to the study worth discussing. First, 
we used a novel surrogate outcome variable of poor neurologic 
outcome defined as those patients who had been granted per-
manent disability allowance or permanent disability pension 
by the SII. Compared with the commonly used Glasgow Out-
come Scale, our definition may include a degree of inaccuracy 
even though it is similar to the Glasgow Outcome Scale defini-
tion of unfavorable outcome, that is, the patient is unable to 
live independently (27). Still, since our study was conducted 
in a public tax-funded healthcare system, where by law all citi-
zens have the right to disability allowances, we believe that our 
definition of permanent disability adequately reflects neuro-
logic outcome. Second, the noticed shift in practice toward 
treating older patients with milder injuries might affect overall 
sum of costs. Yet, it should not affect cost-effectiveness, as this 
was controlled for by performing subgroup analyses in pre-
defined TBI severity and age groups. Finally, our study comes 
from one single country in Northern Europe with a tax-funded 
healthcare system. Thus, our results are best generalizable to 
countries with similar healthcare systems and one should not 
directly generalize our results to other countries with other 
types of healthcare funding.
CONCLUSION
During the last decade, healthcare costs of ICU-admitted TBI 
patients have remained largely the same in Finland. No change 
in mortality was noted, but the risk for permanent disability 
decreased significantly. Thus, our results suggest that cost-effec-
tiveness of TBI care has improved during the past decade in Fin-
land. Due to the increase need for ICU care of mild TBI and elderly 
TBI patients, overall TBI-related healthcare costs have increased. 
Yet, cost-effectiveness of TBI care appears to be justifiable when 
compared with patients with other forms of critical illness.
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